Thames Clinical Trial
Patients with Diabetic Macular Edema (open for recruitment)
This is a clinical trial aiming to look at the safety and effects of an investigational medication injected into the eye to DME. Treatment for this trial includes injections of the investigational medication in combination with other FDA approved diabetic macular edema medications.
This is for adults diagnosed with diabetic macular edema in either eye. Review more details on this study at ClinicalTrials.gov.
Pagoda Clinical Trial
Patients with Diabetic Macular Edema (closed for recruitment)
The purpose of this study is to investigate the effects and safety of the Port Delivery System (PDS) in patients with Diabetic Macular Edema (DME). The PDS is an investigational drug delivery technology that allows physicians to continuously treat the eye with medication rather than frequent intravitreal injections.
Diabetic macular edema (DME) is the term used for swelling in the small central part of the retina used for sharp, straight ahead vision due to diabetes. The retina is a thin layer of tissue that lines the back of your eye. It is nourished by blood vessels that become affected by diabetes.
All participants will receive either Ranibizumab injections or the investigational Port Delivery System with Ranibizumab. No one will receive a placebo. Review more details on this study at ClinicalTrials.gov.